ASCEND BY NTHRYS
Research Abroad Products

Molecular Oncology Project Topics

Browse all focused areas across all project categories under this field.

Showing 1–12 of 220 project topics
AI-Powered Cancer Mutation Database Platform
A commercial SaaS platform that aggregates, annotates, and predicts oncogenic mutations using machine learning to identify novel drug targets. Enables pharmaceutical companies to reduce target validation time by 60% and accelerate lead compound discovery workflows.
Molecular Oncology Drug Target Discovery Tools Click to view more details →
High-Throughput Protein-Ligand Screening Service
An outsourced screening service utilizing robotic automation and AI image analysis to test thousands of drug-like compounds against cancer protein targets daily. Generates recurring revenue through per-screening contracts while reducing client R&D infrastructure costs by 40%.
Molecular Oncology Drug Target Discovery Tools Click to view more details →
Genomic Data Integration and Target Prioritization Tool
A cloud-based analytics platform that integrates TCGA, GEO, and proprietary genomic datasets to identify and rank actionable cancer driver genes with commercial potential. Monetizes through enterprise licensing to biotech firms seeking validated target candidates for their pipelines.
Molecular Oncology Drug Target Discovery Tools Click to view more details →
Synthetic Lethality Interaction Prediction Engine
A proprietary computational tool that models synthetic lethal and paralog-dependent interactions to uncover novel combination therapy targets in cancer cells. Delivers premium licensing fees by enabling clients to design multi-target inhibitor programs with higher clinical success rates.
Molecular Oncology Drug Target Discovery Tools Click to view more details →
Patient-Derived Xenograft Profiling and Matching Service
A biobank-linked service that develops tumor models, performs target-pathway profiling, and matches compounds to patient tumors for precision oncology applications. Creates sustainable revenue through model licensing, molecular profiling fees, and downstream hit-to-lead service contracts.
Molecular Oncology Drug Target Discovery Tools Click to view more details →
CRISPR-Based Functional Target Validation Platform
A turnkey service offering pooled or arrayed CRISPR screening combined with rapid phenotypic readouts to validate cancer drug targets in relevant cellular backgrounds. Charges per-screen fees to accelerate client validation pipelines while providing IP-defensible target data packages.
Molecular Oncology Drug Target Discovery Tools Click to view more details →
Immunotherapy Target Discovery and Biomarker Analytics
A specialized SaaS platform analyzing immune cell infiltration, checkpoint expression, and neoantigen landscapes to identify tumor-specific immunotherapy targets. Monetizes through tiered licensing with premium features for biomarker prediction and patient stratification workflows.
Molecular Oncology Drug Target Discovery Tools Click to view more details →
Live-Cell Kinase Target Engagement and Activity Assay
A proprietary cell-based assay platform measuring real-time kinase target engagement and downstream signaling in native tumor contexts without overexpression artifacts. Generates service revenue through per-compound screening contracts and tool licensing to pharma R&D teams.
Molecular Oncology Drug Target Discovery Tools Click to view more details →
Cancer Dependency Map and Target Ranking Software
An enterprise software suite integrating transcriptomic, proteomic, and functional dependency data to rank drug targets by exploitability and commercial potential across cancer types. Captures recurring software subscription revenue while enabling clients to reduce target attrition rates by 35%.
Molecular Oncology Drug Target Discovery Tools Click to view more details →
Structural Oncology AI Design and Validation Service
A service combining AlphaFold-based structural prediction with high-throughput virtual screening to design selective binders to difficult cancer targets and validate their function. Monetizes through structure-guided design contracts, IP licensing, and hit compound validation services.
Molecular Oncology Drug Target Discovery Tools Click to view more details →
Real-time Oncogene Mutation Detection SaaS Platform
Cloud-based platform that continuously monitors and identifies oncogenic mutations across patient samples using NGS data integration and AI-powered variant calling. Enables laboratories to reduce turnaround time and increase throughput, generating recurring subscription revenue through tiered pricing models.
Oncogene & Tumor Suppressor Analytics Platforms Click to view more details →
Tumor Suppressor Gene Loss Prediction Analytics Engine
Commercial software tool that predicts loss-of-function mutations in tumor suppressor genes using machine learning on genomic datasets. Supports precision oncology workflows and licensing partnerships with pharmaceutical companies seeking biomarker validation services.
Oncogene & Tumor Suppressor Analytics Platforms Click to view more details →